5 things to know in life sciences: Week of Aug. 18, 2025
Heart devices lead medtech’s summer financing surge. This and more in this week’s life sciences update.| The Real Economy Blog
While nominal gains in spending and income look strong on the topline, adjusting for inflation is necessary—and subsequently implies an economy that is growing just above 1 percent. ... READ MORE >| The Real Economy Blog
Manufacturers continue to expect higher input prices while holding mixed expectations regarding capital expenditure in the next six months. ... READ MORE >| The Real Economy Blog
Each week we highlight five things affecting the life sciences industry. Here’s the latest. ... READ MORE >| The Real Economy Blog
As China continues to flood its external market with cheap goods, Germany finds itself to be a willing partner, trading its low value-added manufacturing sector for the disinflation of cheap goods. ... READ MORE >| The Real Economy Blog
The euro, yuan, pound and yen do not have the adequate depth to support the liquidity needs of the global systematically important banks. ... READ MORE >| The Real Economy Blog
The Health Resources and Services Administration has announced a pilot program with changes to the 340B Drug Pricing Program. ... READ MORE >| The Real Economy Blog
Reliance on the front end of the Treasury curve, and a drawdown in the repo facility, open the government to the risk of increased volatility, ... READ MORE >| The Real Economy Blog
Beijing’s current policies are likely to continue what is shaping up to be an extended period of private sector deleveraging. ... READ MORE >| The Real Economy Blog
Heart devices lead medtech’s summer financing surge. This and more in this week’s life sciences update.| The Real Economy Blog
The Real Economy Blog from RSM US LLP was developed to provide timely economic insights about the middle market economy.| The Real Economy Blog
Each week we highlight five things affecting the life sciences industry. Here’s the latest.| The Real Economy Blog
The latest estimate of gross domestic product in the third quarter came out stronger than expected, rising by 3.1% instead of 2.8%.| The Real Economy Blog
The 32.9% decline in U.S. gross domestic product is the single largest decline in the report since the collection of the data began in 1947. But the reopening of the economy that begin around May 1…| The Real Economy Blog
From our point of view, the economy will likely soon meet the formal definition of being in a recession, though it isn’t there yet.| The Real Economy Blog
Once one excludes the more volatile trade and inventory data, growth advanced at a much softer pace of 1.2% implied by final sales to private domestic purchasers.| The Real Economy Blog
Ontario and B.C. home prices are down and sales are expected to slip further, meaning buyers can catch the market off-balance now before it’s set to rebound.| The Real Economy Blog
A rapid decline in inflation amid robust hiring and an unemployment rate that stands at 3.6% despite a steep rise in interest rates underscore a resilient American economy that refuses to go gently…| The Real Economy Blog
Subscribe to the RSM Market Minute and receive regular articles to your inbox.| The Real Economy Blog
July Fed rate cut still on the table| The Real Economy Blog
The dovish turn at the Federal Open Market Committee’s January meeting was predicated on an interesting juxtaposition: the committee telegraphed a prudent pause in its policy normalization campaign…| The Real Economy Blog
We now expect growth to slow to 1.1% this year, inflation to rise above 3% and a 4.4% unemployment rate.| The Real Economy Blog
We expect the 10-year yield to remain in a range between 4% and 4.5% amid of elevated volatility and now expect it to finish the year near 4.35% with risk of a lower rate.| The Real Economy Blog
National average prices that were over $5 per gallon in early 2022 at the start of the Ukraine war dropped to $3.30 in May.| The Real Economy Blog
These trends will continue to be a driving force when capital markets organizations are determining their strategies and operations for the rest of 2025 and beyond.| The Real Economy Blog
It is becoming increasingly likely that the froth in the markets for digital assets and the risk it brings are why federal authorities have begun signaling stepped-up scrutiny.| The Real Economy Blog
April was marked by significant volatility, driven by U.S. tariffs on trading partners. Last month also saw a few key mergers and acquisitions, along with crypto regulatory advancements.| The Real Economy Blog
As the regulatory and technology landscape continues to evolve, broker-dealers, exchanges, and clearinghouses must proactively adjust to these changes to get the most out of evolving investor behaviors.| The Real Economy Blog
The extend-and-pretend deadlines on tariffs have turned into a never-ending moving of the goal posts that investors now discount.| The Real Economy Blog
The ambulatory care sector has emerged as the labor bellwether of the health care industry, representing 48% of all health care hires.| The Real Economy Blog
The latest CPI data also underscores a persistent rise in hospital and related services, signaling escalating cost pressures for health care consumers.| The Real Economy Blog
We’re exploring the trends affecting the health care industry. Here’s the latest: Expanding role of paramedics in hospital-at-home models.| The Real Economy Blog
As Congress moves toward finalizing the sweeping One Big Beautiful Bill Act, a fierce debate over Medicaid funding has taken center stage.| The Real Economy Blog
Even if the strike is resolved quickly and significant damage is avoided, this strike is the latest of events that highlight the need for companies to develop supply chain resiliency.| The Real Economy Blog
